Powered by: Motilal Oswal
30/06/2023 5:05:54 PM | Source: Religare Broking Ltd
Stock of the day: Buy Sun Pharmaceutical Industries Ltd For Target Rs. 1,180 - Religare Broking
News By Tags | #5695 #1126 #3050
Stock of the day: Buy Sun Pharmaceutical Industries Ltd For Target Rs. 1,180 - Religare Broking

Sun Pharmaceutical Industries Ltd.

Rationale

* Open Interest in stock is 40k v/s 34k contracts in previous series; Rise of ~17%.

* 93% positions rolled into next series as compare to 94% on last expiry.

* Cash based buying & carrying forward longs suggesting positional players have added aggressively

 

Technical View

* We have witnessed a trend reversal in the pharma index after more than one and a half years and trading up by over 8% this month so far.

* We are seeing noticeable traction across the pack wherein Sunpharma also looks set to resume the trend after spending nearly seven months in a consolidation range.

* Traders shouldn’t miss the opportunity and accumulate in the given range.

Buy Sun Pharmaceutical Industries Ltd CMP 1050; Range 1040-1050; SL 980; Target 1180

 

 

To Read Complete Report & Disclaimer Click Here

 

Please refer disclaimer at https://www.religareonline.com/disclaimer

SEBI Registration number is INZ000174330

 

Views express by all participants are for information & academic purpose only. Kindly read disclaimer before referring below views. Click Here For Disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here